GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Abbott Laboratories (ABT) [hlAlert]

Rating:
Buy ABT
up 31.14 %

Abbott Laboratories (ABT) rated Buy with price target $40 by Stifel Nicolaus

Posted on: Monday,  Feb 18, 2013  8:25 AM ET by Stifel Nicolaus

Stifel Nicolaus rated Buy Abbott Laboratories (NYSE: ABT) on 02/18/2013. Previously Stifel Nicolaus rated Buy Abbott Laboratories (NYSE: ABT) on 02/15/2013.,
when the stock price was $34.80. Since then, Abbott Laboratories has gained 31.15% as of 10/07/2015's recent price of $45.64.
If you would have followed the previous Stifel Nicolaus's recommendation on ABT, you would have gained 31.14% of your investment in 964 days.

Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott comprehensive line of products encircles life itself addressing important health needs from infancy to the golden years.

Stifel Nicolaus research focuses on all market caps, but is a leader in small- and mid-cap research. The department is staffed predominately with industry professionals from outside Wall Street. In fact, approximately 50% of its analysts have hands-on work experience in the industry that they research. Stifel Nicolaus believes industry experience, its opportunistic approach, and broad market cap coverage drive excess returns and its award-winning franchise.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/18/2013 8:25 AM Buy
None
40.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/15/2013 8:25 AM Buy
None
34.80 40.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy